Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
95.17
+2.56 (2.76%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$385,408
Profits / Employee
-$147,108
Market Cap
5.40B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
GKOS News
- 1 day ago - Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - Business Wire
- 8 days ago - Glaukos Announces the Release of its 2024 Sustainability Report - Business Wire
- 15 days ago - Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30 - Business Wire
- 6 weeks ago - RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution - Business Wire
- 2 months ago - FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Benzinga
- 2 months ago - Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™ - Business Wire
- 2 months ago - Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Benzinga
- 2 months ago - Glaukos Corporation (GKOS) Q4 2024 Earnings Call Transcript - Seeking Alpha